The FINANCIAL -- An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers at the University of Pennsylvania and Penn’s Perelman School of Medicine.…
Read More »
The FINANCIAL -- An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers at the University of Pennsylvania and Penn’s Perelman School of Medicine.…
You might be interested in
It’s like we forgot how to drive, one Harvard expert observed recently about the two-year spike in traffic-related deaths, which…
SARS-CoV-2 infection can trigger the production of immune molecules that damage cells lining blood vessels in the brain, causing platelets…
The FINANCIAL — Researchers have found that around one in 500 men could be carrying an extra X or Y…
The FINANCIAL — COVID-19 was the third leading cause of death in the United States between March 2020 and October…